Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on November 9, 2004, detailing significant financing activities related to a tender offer for its common stock. The company entered into two new credit facilities: a $2.5 billion "Permanent Facility Agreement" and a $1.25 billion "Short-Term Facility Agreement." These new agreements are designed to refinance existing debt, fund a portion of a substantial share repurchase program, and cover general corporate purposes. Notably, the entry into the $2.5 billion Permanent Facility Agreement necessitated the repayment and termination of HCA's previous $2.5 billion credit agreement, with no material early termination penalties incurred. The Permanent Facility consists of a $750 million term loan and a $1.75 billion revolving credit facility, both with a five-year maturity. The Short-Term Facility provides $1.25 billion through a term loan with a six-month maturity, specifically to aid in the completion of the tender offer. The financing arrangements are subject to customary conditions, including minimum credit ratings and the successful execution of the tender offer.
Key Highlights
- 1HCA entered into two new credit facilities totaling $3.75 billion on November 9, 2004.
- 2The $2.5 billion Permanent Facility Agreement will refinance existing debt, fund the tender offer, and support general corporate purposes.
- 3The $1.25 billion Short-Term Facility Agreement is specifically to finance the ongoing tender offer for HCA's common stock.
- 4The new Permanent Facility comprises a $750 million term loan and a $1.75 billion revolving credit facility, each with a five-year maturity.
- 5The Short-Term Facility is a $1.25 billion term loan with a six-month maturity.
- 6HCA terminated its prior $2.5 billion credit agreement upon entering the new Permanent Facility, incurring no significant early termination penalties.
- 7Both new credit agreements are subject to customary closing conditions, including minimum credit ratings (BB+/Ba2) and the successful consummation of the tender offer.